1. Nanoparticles of Metal-Organic Cages Overcoming Drug Resistance in Ovarian Cancer
- Author
-
Han Wang, Zihan Qiu, He Liu, Amarasooriya M. D. S. Jayawardhana, Zhizhou Yue, Hala Daghlas, David J. Bowers, Bansidhar Datta, and Yao-Rong Zheng
- Subjects
metal-organic cages ,nanoprecipitation ,DNA damage ,host-guest chemistry ,drug resistance ,Chemistry ,QD1-999 - Abstract
A long-standing challenge in the treatment of ovarian cancer is drug resistance to standard platinum-based chemotherapy. Recently, increasing attention has been drawn to the use of self-assembled metal-organic complexes as novel therapeutics for cancer treatment. However, high hydrophobicity that is often associated with these structures lowers their solubility and hinders their clinical translation. In this article, we present a proof-of-concept study of using nanoprecipitation to formulate the hydrophobic metal-organic cages and facilitate their use in treating chemoresistant ovarian cancer. The Pt6L4 Cage 1 is an octahedral cage formed by self-assembly of six 1,10-phenanthroline-Pt(II) centers and four 2,4,6-tris(4-pyridyl)-1,3,5-triazine ligands (L). Cage 1 is able to trigger DNA damage and exhibits promising in vitro potency against a panel of human ovarian cancer cell lines. However, due to the large portion of aromatic components, this cage structure has very limited solubility in cell culture media (
- Published
- 2019
- Full Text
- View/download PDF